Helping Healthy Aging Towards "Healthy China 2030"
SHANGHAI, Nov. 1, 2021 /PRNewswire/ -- Today, Johnson & Johnson China announced its support to the China Foundation for Primary Health Care (the "Foundation") in launching a community-based capacity building program for the prevention and treatment of common diseases in the elderly. Johnson & Johnson will donate 3 million RMB annually for five consecutive years to support the annual training of 4,000 community health workers and benefit 400,000 residents in communities or villages. As a series of activities of the Chinese Physicians Public Welfare Conference - National Health Communication Action, the project is hosted by the Chubao Foundation, donated by the Johnson & Johnson Foundation, and donated to Asia to manage the donation. At the beginning of the project, the prevention and treatment capacity building of common chronic diseases of the elderly will be carried out around the "atrial fibrillation" and "cataract", aiming to improve the cognitive level and prevention and treatment ability of community health workers on common diseases of the elderly, and establish the scientific prevention and treatment concept of common diseases of the elderly.
Launching Ceremony of the Community Geriatric Common Disease Prevention and Control Capacity Building Project (from left: Professor Zhong Jingquan, Vice Chairman of the China Atrial Fibrillation Center Alliance, Cao Xirong, Chairman of the China Primary Health Care Foundation, Wang Liping, Chairman of johnson & Johnson Global Community Impact Committee in China, Yuan Mei, Chinese mainland actress and producer, and Li Xing, CEO of The Beijing Representative Office of Gift Asia (USA))
According to the data of the seventh national census in 2021, the population aged 60 and over is 264 million people, accounting for 18.70% Compared with 2010, the proportion of the population of the same age group increased by 5.44%[1] According to statistics, there are more than 180 million elderly people in China with chronic diseases, and the proportion of one or more chronic diseases is as high as 75%[2].
Cao Xirong, chairman of the China Primary Health Care Foundation, said: "The aging trend of China's population is becoming increasingly prominent, and the health management of the elderly has become one of the core concerns of the country's basic public health services. Strengthen the health management of the elderly ' the majority of grass-roots health workers urgently need to enhance their awareness of common geriatric chronic diseases and related prevention and control capabilities At the same time, the public should also reserve basic scientific prevention and treatment knowledge of common diseases in the elderly"
Cataracts and atrial fibrillation are two very typical common chronic diseases of the elderly cataract is the world's first blind eye disease, 2020 "China Eye Health White Paper" data show that the prevalence of cataracts in the elderly population aged 60-69 years old is close to 50%, while in the elderly population over 70 years old, the prevalence is as high as 79.2% [3] Xu Wen, member of the Standing Committee of the Ophthalmology Branch of the Chinese Medical Doctor Association, stressed: "Eye health publicity for the elderly in the community is particularly important for cataract prevention and treatment We need to help the elderly understand their own eye health. Enhance the awareness of daily health with the eyes, and clearly recognize that cataracts can be cured through timely surgery, reduce their physical and psychological burden, improve the quality of life, and recommend that patients seek medical treatment in time once they have symptoms such as blurred vision, ghosting, and night blindness."
In addition, China's atrial fibrillation patients exceed 10 million, each year the new atrial fibrillation patients 100,000 people, with the increase in age the prevalence of sharply increased, the latest research shows that the prevalence of people over 45 years old in China is about 1.8%, while the prevalence between 75-84 years old is as high as 12% [4] Professor Zhong Jingquan, vice chairman of the China Atrial Fibrillation Center Alliance and chairman of the Electrophysiology and Pacing Branch of the Shandong Medical Association, said: "The harm of atrial fibrillation is multifaceted, which can increase the risk of stroke by 5 times and the risk of heart failure by 3 times. The risk of dementia and death has increased by 2 times, significantly reducing the quality of life of patients, and also causing a huge economic burden to society and individuals.
Wang Liping, China Chair of Johnson & Johnson Global Community Impact Committee, said: "In this year's 14th Five-Year Plan strategy, ' As a leader in the medical industry, Johnson & Johnson attaches great importance to helping the community build capacity for the prevention and treatment of common diseases in the elderly, strengthening support for the grass-roots health worker team, and providing grass-roots medical and health services for the general public We hope to help 200,000 grass-roots health workers by 2030 and benefit 20 million people, and actively contribute to the early realization of the great goal of 'Healthy China 2030'"
The Johnson & Johnson Foundation donated RMB 3 million to the China Primary Health Care Foundation
The 2021-2022 community geriatric common disease prevention and control capacity building project plans to carry out pilots in Beijing, Shanghai, Guangzhou, and Hunan, first training community health workers, improving their professional skills, and then entering the community for education and practice, helping the community to establish the concept of health prevention, do a good job in health management, and jointly with new media platforms, with the help of expert authoritative credibility and public influence, carry out national health communication, and continue to deepen health education and science popularization for community health workers and the public. Enhance the public's awareness of the prevention and treatment of common diseases in the elderly.
As a multinational healthcare company with extensive global business distribution, Johnson & Johnson is committed to using a wide range of influences to promote human health, advance global health, and build a better society Johnson & Johnson mainly through the development of medical staff capacity building projects to improve the health and well-being of communities January 2020, Johnson & Johnson announced a commitment to invest $250 million to meet the goal of helping 1 million healthcare workers around the world reach 100 million people by 2030, and China is one of the ten core regions of the goal In March 2020, Johnson & Johnson pledged an additional $50 million to support the global frontline healthcare workers in the fight against the epidemic.
[1] "The Main Data of the Seventh National Census", Ning Jizhe, deputy head of the Leading Group of the Seventh National Population Census of the State Council and director of the National Bureau of Statistics, national bureau of statistics.
[2] Transcript of the Press Conference of the Office of the Healthy China Action Promotion Committee on July 29, 2019, Department of Publicity, National Health Commission of the People's Republic of China, July 29, 2019
[3] China Eye Health White Paper, National Anti-Blindness Technical Guidance Group, Science and Technology Literature Press, 2020.6
[4] Atrial Fibrillation White Paper: The Value of Early Diagnosis and Early Treatment for Atrial Fibrillation Surgery, Biosense Webster®